Pharmaceuticals.jpg

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

20283-92-5

Rosmarinic acid

20283-92-5
05/08/3641

Ribavirin Related Compound D

05/08/3641
153-18-4

Rutin

153-18-4
39925-19-4

Ribavirin Related Compound A

39925-19-4
87269-97-4

Ramiprilat

87269-97-4
122320-73-4

Rosiglitazone

122320-73-4
80223-99-0

Racemic Tamsulosin HCl USP

80223-99-0
207671-50-9

Rutin Hydrate

207671-50-9
50-55-5

Reserpine

50-55-5
105462-24-6

Risedronic Acid

105462-24-6
81-88-9

Rhodamine B

81-88-9
58543-16-1

Rebaudioside A

58543-16-1
723-46-6

Sulfamethoxazole

723-46-6
57-68-1

Sulfamethazine

57-68-1
68-35-9

Sulfadiazine

68-35-9
55-16-3

Scopolamine HCl

55-16-3
153-98-0

Serotonine HCl

153-98-0
69-72-7

Salicyclic acid

69-72-7
127-79-7

Sulfamerazine

127-79-7
80-32-0

Sulfachloropyridazine

80-32-0